Breaking News, Collaborations & Alliances

WuXi, J&J in Preclinical Pact

WuXi and J&JPRD have established a preclinical services and training agreement

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

WuXi PharmaTech (Cayman) Inc. and Johnson & Johnson Pharmaceutical R&D, a Janssen subsidiary, have agreed to collaborate in the area of preclinical services. WuXi will become a provider of toxicology and other non-clinical services to Janssen, which will provide training and other services, reimbursed by WuXi, to establish the GLP quality system and technical capabilities to meet the international standards at WuXi’s toxicology facility in Suzhou, China. Construction of this 314...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters